Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 189.00
-4.95 (-2.55%)
At close: Jul 7, 2026
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 6.61 billion as of July 7, 2026. Its market cap has decreased by -11.44% in one year.
Market Cap
6.61B
Enterprise Value
6.78B
Revenue
2.35B
Ranking
n/a
PE Ratio
21.21
Stock Price
189.00
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 6.61B, an increase of 46,003.43%. That is a compound annual growth rate of 28.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 6.61B | 17.11% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermenta Biotech | 10.18B |
| Wanbury | 10.02B |
| Bharat Parenterals | 9.54B |
| Sudarshan Pharma Industries | 9.50B |
| Kopran | 9.39B |
| Hexagon Nutrition | 8.73B |
| Anuh Pharma | 8.04B |
| ZIM Laboratories | 6.59B |